Announcements

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are currently recruiting Editorial Board Members (EBMs) for MDPI journals indexed in the Emerging Sources Citation Index (ESCI) in Web of Science. In particular, we are looking for experts who are interested in aiding in the development of our journals and safeguarding the scientific quality of the published findings.

Journals currently listed in the ESCI will receive an Impact Factor in June 2023, according to the changes announced by Web of Science (Clarivate). Therefore, this is an excellent time to become an Editorial Board Member for one of these fast-developing journals.

If you are interested in sharing your expertise in one of the journals listed below, please send us an application using this link.

The Editorial Office of the journal will contact you once the application has been approved.
Editorial Board Members are responsible for academic decisions on manuscripts in their field of expertise, will edit Special Issues, and may be invited to review manuscripts. The initial term lasts for two years, after which it can be renewed, and entails the following:

• Prescreening and making decisions on new submissions related to your research interests;
• Setting up at least one Special Issue during your term on a topic related to your research interests (or supervising Special Issues related to your research field);
• Providing input or feedback regarding journal policies;
• Helping to promote the journal among your peers or at conferences;
• Attending Board meetings to suggest journal development strategies;
• Reviewing manuscripts.

Editorial Board Members are entitled to a full waiver on one publication per year in the journal that they serve and need to be experts in their fields.

The list of ESCI journals can be found here: https://www.mdpi.com/about/journals/esci.

Please find the list of ESCI journals, categorized by subject, for which we are recruiting Editorial Board Members below.

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

MDPI will be attending the 15th European Public Health Conference 2022, held in Berlin, Germany, from 9 to 12 November 2022. The theme of Berlin 2022 is “Strengthening Health Systems: Improving Population Health and Being Prepared for the Unexpected”. This conference will aim to explore ways in which the public health community can rally around the principle of bringing about better population health. Meanwhile, the conference committee wants the discussions at the 15th EPH Conference to contribute to resilient health systems, universal health coverage (UHC), a well-trained and highly qualified clinical and public health workforce, and governance structures that take a stand and shape health systems globally.

During this conference, MDPI (at booth #13) will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• IJERPH;
• Medicina;
• JCM;
• EJIHPE;
• Epidemiologia;
• Behavioral Sciences;
• Healthcare;
• Women;
• MPs;
• Nursing Report;
• COVID;
• Diseases;
• Data;
• Adolescents.

If you plan on attending this conference, feel free to stop by our booth at #13. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://ephconference.eu/index.php.

We are pleased to announce that Nursing Reports (ISSN: 2039-4403) has been selected for coverage in the Scopus indexing database in October 2022. We would like to extend our sincerest gratitude to all the authors, reviewers, and editors who have contributed to this journal and helped accomplish this achievement. 

At the same time, Nursing Reports continues to be covered in ESCI (Web of Science) and will receive an Impact Factor from the Web of Science in June 2023. 

Nursing Reports provides an opportunity for nurse researchers and scholars to make a unique and important contribution to nursing and the broader health care community by addressing topics, theories, and issues that concern the discipline of nursing, including research, practice, policy, and education. 

To make the most of this opportunity, we would like to invite you to submit your research to the journal. If you have a paper concerning any topic within the scope of the journal, please feel free to submit it at the following link: https://susy.mdpi.com/user/manuscripts/upload/?journal=nursrep. 

Nursing Reports Editorial Office

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
• Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

• Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

• Helen Rogers, Newcastle University, UK

Healthcare:

• Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

• Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

• Simone Di Franco, University of Palermo, Italy
• Catriona Hippman, University of Calgary, Canada

Medicina:

• Veeru Kasivisvanathan, University College London, UK
• Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

• Qi Zhou, Purdue University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

• Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

• Shawn Alexander Hallett, University of Michigan, USA

Medicines:

• Claire Albert, Yale University, USA

Pharmaceuticals:

• Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
• Patrick Jim Küppers, University Hospital Bonn, Germany

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

• Antonio G. Solimando, University of Bari Aldo Moro, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Joaquim Carreras, Tokai University, Japan
• Pierfrancesco Franco, University of Turin School of Medicine, Italy
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

• Margaret Fitch, University of Toronto, Canada
• Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

• Naser Alsharairi, Griffith University, Australia
• Peter W. Choate, Mount Royal University, Canada
• Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

• Giulio Francesco, Sapienza University of Rome, Italy
• Sebastian Schnaubelt, Medical University of Vienna, Austria
• Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

• Onofrio Laselva, University of Foggia, Italy
• Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
• Vladimir Vladimirov, Virginia Commonwealth University, USA
• Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

• Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

• Anjul Khadria, California Institute of Technology, Pasadena, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials”

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

• “Antibiotic Discovery: Where Have We Come from, Where Do We Go?”

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

• “Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients”

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

• “Treatment of Peri-Implant Mucositis with Repeated Application of Chlorhexidine Chips or Gel during Supportive Therapy—A Randomized Clinical Trial”

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

• “Two-Year Use of Care Robot Zora in Dutch Nursing Homes: An Evaluation Study”

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

• “The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus”

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

• “Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues”

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

• “The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity”

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

• “Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR”

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

• “Tumor Microenvironment”

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

• “Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study”

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

• “3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology”

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

• “Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems”

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140